Public Release: 

2014 AAPS National Biotechnology Conference heads to San Diego

Annual event devoted to innovations in biotherapeutics will unveil new conference workstreams

American Association of Pharmaceutical Scientists

WHO: The American Association of Pharmaceutical Scientists is a professional, scientific society of approximately 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to serve the public and enhance their contributions to health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development. Visit today. Follow us on Twitter @AAPSComms; official Twitter hashtag for the meeting is #2014NBC.

WHAT: The 2014 AAPS National Biotechnology Conference (NBC) will gather scientists from industry, government, and academia for three days of educational offerings specifically geared toward the biotechnology sector of the pharmaceutical sciences. This year, attendees will be able to attend one conference organized into four conference workstreams: biomanufacturing, biomarker and Pharmacokinetic/Pharmacodynamic (PK/PD), research and discovery, and immunogenicity and administration routes. An integrated program will examine both theory and application from multiple perspectives including discovery, development, engineering, and regulatory aspects.

The 2014 NBC programming will consist of a plenary session, 20 symposia, 6 roundtables, contributed paper poster presentations, four hot topics, and a late-breaking session. Additionally, an exposition hall will be hosting over 110 major companies featuring new technologies. There will also be job boards available highlighting new, biotechnology career opportunities.

WHEN: May 19-21, 2014

WHERE: Sheraton San Diego Hotel and Marina, San Diego, CA


  • Kári Stefánsson, Ph.D. - president, chairman, CEO, and co-founder of deCODE Genetics
  • Victoria Hale, Ph.D. - founder of Medicines 360, pharmaceutical scientist, and global health social entrepreneur
  • Peter J. Schultz, Ph.D. - professor, The Scripps Research Institute


For the most up-to-date program information, please visit

Editor's Note: ALL PRESS MUST BE REGISTERED AND PROVIDE PRESS CREDENTIALS TO ATTEND THIS MEETING. For media registration prior to the conference, please contact Kimberly Brown at +1-703-248-4772 or

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.